SB 146 expands mental wellness services provided by Oklahoma's Department of Public Safety to include retirees of public safety personnel (such as police and firefighters), in addition to current employees. It creates a dedicated revolving fund (Section 9102) to finance these services and strengthens privacy protections by prohibiting the sharing of individual mental health data without consent, while allowing aggregate data use for policy improvements (Section 9101). The bill also mandates that all Mental Wellness Division resources operate separately from other department divisions. These changes took effect November 1, 2025, after becoming law without the Governor's signature on May 29, 2025.
SB 392 extends the expiration date of Oklahoma's Long-Term Care Facility Advisory Council from July 1, 2025, to July 1, 2026. The council, which advises on standards for nursing homes, residential care facilities, and adult day care services, continues with its existing structure of 13 members including healthcare professionals and public representatives over age 65. This extension ensures uninterrupted review of care quality, facility regulations, and enforcement under the Nursing Home Care, Residential Care, and Adult Day Care Acts. The bill does not alter the council's duties or membership requirements.
HB 2051 creates Oklahoma's "Supervised Physicians Act," establishing a temporary pathway for medical school graduates to practice under supervision. It directly affects Oklahoma medical school graduates who have passed required exams but lack full licensure, requiring them to enter a collaborative practice arrangement with a fully licensed Oklahoma supervising physician who meets specialty qualifications. Key provisions include a two-year temporary license (non-renewable), mandatory identification as a "supervised physician" via name tags/lab coats, and prohibitions against independent practice without the approved arrangement. The bill does not create a full licensure alternative but sets specific rules for this supervised practice period, with oversight by the State Board of Medical Licensure.
SB 1352 modifies Oklahoma's medical marijuana licensing rules by requiring municipalities to provide specific documentation before blocking license renewals or transfers for dispensaries located too close to schools. It mandates that local governments submit a resolution proving a school was "openly in existence" (with visible signage) before the dispensary opened, plus verified distance measurements using a standardized method. This affects existing medical marijuana businesses seeking renewal or transfer of retail dispensary licenses. The bill aims to prevent automatic renewal of dispensaries near schools without proper municipal review, while requiring certificate of occupancy compliance for facility operations.
SB 943, the Oklahoma Medical Freedom Act, protects Oklahomans' right to refuse medical treatments, vaccines, or procedures without discrimination in employment, public accommodations, or legal rights. It prohibits healthcare licensing boards from disciplining professionals who voice concerns about mandates, advocate for patient autonomy, or report unethical practices. The bill creates a legal cause of action for healthcare workers facing retaliation, allowing them to seek injunctive relief, damages, and expedited court review. It directly affects Oklahoma residents exercising medical choices and healthcare professionals speaking out against coercive policies.
HB 2807 creates a new "medical marijuana transporter license" category for businesses handling medical marijuana products. It allows licensed transporters (including current growers, processors, dispensaries, and new applicants) to operate warehouses with annual permits, maintain security-compliant storage, and use a state tracking system for all shipments. The bill requires GPS trackers on transport vehicles, labeled secure containers, and detailed inventory manifests documenting all movements. These provisions directly affect medical marijuana businesses, transporters, and warehouses by standardizing transportation rules and enhancing product tracking across Oklahoma.
SB 518 requires medical marijuana businesses in Oklahoma to use specific warning labels on all products sold to licensed patients. The labels must include mandatory statements like "For use by licensed medical marijuana patients only," "Keep out of reach of children," and warnings about driving under influence and pregnancy risks, along with potency details (THC/cannabinoids) and contaminant testing information. The law prohibits child-targeted packaging (such as cartoon characters) and bans health benefit claims on product containers. It applies to all medical marijuana businesses and takes effect November 1, 2025, after becoming law without the governor's signature on May 21, 2025.
SB 993 regulates how pharmacy benefit managers (PBMs) audit pharmacies in Oklahoma. It requires PBMs to provide 14 days' notice (30 days for wholesale audits) before audits, prohibits treating simple clerical errors (like typos or computer mistakes) as fraud, and bans recouping funds for such errors without proof of intentional fraud. The bill also mandates that if funds are recouped, pharmacies must refund patients first, and PBMs must conduct audits using licensed pharmacists for clinical judgments. This directly affects pharmacies and PBMs by setting clear standards for audit processes and preventing unfair financial penalties.
HB 1740 requires Oklahoma's Department of Mental Health and Substance Abuse Services (ODMHSAS) to create written, individualized service plans within 45 days for people found not guilty by reason of mental illness (NGRI/MI). These plans must be based on comprehensive psychological and psychiatric evaluations, include specific details like treatment history and service schedules, and be written in plain language. The court must approve the plan after reviewing it with input from the individual, their attorney, and treating doctors, and the plan must be updated regularly. The bill also mandates frequent court review hearings - four quarterly in the first year, then two semi-annually - and requires ODMHSAS to provide detailed reports to the court before each hearing.
SB 927 amends Oklahoma's Medicaid Drug Utilization Review Board procedures by prohibiting the pharmaceutical industry representative from voting on drug-related matters. It updates the appointment process to stagger initial terms for one physician, one pharmacist, and the lay representative to ensure board continuity. The bill affects the Oklahoma Health Care Authority and the board members, with changes taking effect November 1, 2025. The board's composition (10 members: 4 physicians, 4 pharmacists, 1 lay representative, 1 pharmaceutical industry rep) and appointment lists remain unchanged.
